New Zealand markets closed

Gilead Sciences, Inc. (GILD)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
83.16+2.22 (+2.74%)
At close: 04:00PM EDT
82.54 +0.15 (+0.18%)
Pre-market: 04:08AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 103.53B
Enterprise value 124.11B
Trailing P/E 101.41
Forward P/E 11.60
PEG ratio (5-yr expected) 0.49
Price/sales (ttm)3.74
Price/book (mrq)5.66
Enterprise value/revenue 4.46
Enterprise value/EBITDA 23.55

Trading information

Stock price history

Beta (5Y monthly) 0.20
52-week change 39.90%
S&P500 52-week change 325.74%
52-week high 387.87
52-week low 362.07
50-day moving average 374.90
200-day moving average 373.37

Share statistics

Avg vol (3-month) 37.01M
Avg vol (10-day) 36.86M
Shares outstanding 51.24B
Implied shares outstanding 61.24B
Float 81.24B
% held by insiders 10.12%
% held by institutions 187.92%
Shares short (15 Aug 2024) 416.77M
Short ratio (15 Aug 2024) 42.61
Short % of float (15 Aug 2024) 41.35%
Short % of shares outstanding (15 Aug 2024) 41.35%
Shares short (prior month 15 Jul 2024) 421.25M

Dividends & splits

Forward annual dividend rate 43.08
Forward annual dividend yield 43.70%
Trailing annual dividend rate 33.04
Trailing annual dividend yield 33.76%
5-year average dividend yield 44.03
Payout ratio 4370.73%
Dividend date 327 Sept 2024
Ex-dividend date 413 Sept 2024
Last split factor 22:1
Last split date 328 Jan 2013

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)30 Jun 2024

Profitability

Profit margin 3.79%
Operating margin (ttm)38.72%

Management effectiveness

Return on assets (ttm)11.55%
Return on equity (ttm)5.26%

Income statement

Revenue (ttm)27.8B
Revenue per share (ttm)22.30
Quarterly revenue growth (yoy)5.40%
Gross profit (ttm)N/A
EBITDA 13.46B
Net income avi to common (ttm)1.05B
Diluted EPS (ttm)0.82
Quarterly earnings growth (yoy)54.50%

Balance sheet

Total cash (mrq)3.78B
Total cash per share (mrq)3.04
Total debt (mrq)23.35B
Total debt/equity (mrq)128.32%
Current ratio (mrq)1.14
Book value per share (mrq)14.67

Cash flow statement

Operating cash flow (ttm)7.47B
Levered free cash flow (ttm)6.79B